10:46 AM EDT, 10/10/2025 (MT Newswires) -- Guardian Pharmacy Services ( GRDN ) is "well-positioned" to benefit from growth in the long-term care market, supported by rising demand from an aging population and a fragmented industry that offers opportunities for consolidation, Oppenheimer said in a report Friday.

The firm initiated coverage of the pharmacy services company with an outperform rating and a $30 price target, citing its exposure to a growing market, stable margin profile, and consistent financial track record as key factors behind the positive view.

The company's growth prospects are supported by a mix of organic expansion and acquisitions, both of which have delivered solid returns historically, according to the note.

While upcoming reimbursement changes tied to the federal government's maximum fair price policy may create some uncertainty, Oppenheimer expects the financial impact to be manageable and already reflected in the company's valuation, according to the report.

Price: 23.73, Change: +0.05, Percent Change: +0.19